Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
Dr Chanock is a leading expert in the discovery and characterisation of cancer susceptibility regions in the human genome. He has received numerous awards for his scientific contributions to our understanding of common inherited genetic variants associated with cancer risk and outcomes. Dr Chanock received his M.D. from Harvard Medical School and completed clinical training at Boston Children’s Hospital and the Dana-Farber Cancer Institute, Boston. From 2001-7, he was a tenured investigator in the Genomic Variation Section of the Pediatric Oncology Branch in the NCI Center for Cancer Research and also served as co-chair of NCI’s Genetics, Genomics and Proteomics Faculty. In 2001, he was appointed as Chief of the Cancer Genomics Research Laboratory, and in 2007 as Chief of the Laboratory of Translational Genomics, both within DCEG. From 2012-3, he served as Acting Co-Director of the NCI Center for Cancer Genomics and was appointed Director of DCEG in 2013. Since 1995, Dr Chanock has served as the Medical Director for Camp Fantastic, a week-long recreational camp for paediatric cancer patients.
